心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

世界卫生组织（WHO）：2021年成人高血压药物治疗指南

2021-08-26 世界卫生组织 世界卫生组织

高血压

WHO颁布首部高血压防治指南，以帮助各国改善高血压管理。

中文标题：

世界卫生组织（WHO）：2021年成人高血压药物治疗指南

英文标题：

Guideline for the pharmacological treatment of hypertension in adults

发布机构：

世界卫生组织

发布日期：

2021-08-26

简要介绍：

WHO颁布首部高血压防治指南，以帮助各国改善高血压管理。该指南是 20 年来首次发布的全球高血压治疗指南，基于最新证据提供了一系列的循证指导，包括起始治疗的血压水平、药物选择、血压监测目标等8大项推荐。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021年成人高血压药物治疗指南 .pdf)] GetToolGuiderByIdResponse(projectId=1, id=c972f1c0021669cb, title=世界卫生组织（WHO）：2021年成人高血压药物治疗指南, enTitle=Guideline for the pharmacological treatment of hypertension in adults, guiderFrom=世界卫生组织, authorId=0, author=, summary=WHO颁布首部高血压防治指南，以帮助各国改善高血压管理。, cover=https://img.medsci.cn/2021829/1630248183948_5579292.png, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Thu Aug 26 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="s1" style="color: #232323;">WHO</span><span class="s2" style="color: #232323;">颁布首部高血压防治指南，以帮助各国改善高血压管理。该指南是</span><span class="s1" style="color: #232323;">&nbsp;20&nbsp;</span><span class="s2" style="color: #232323;">年来首次发布的全球高血压治疗指南，基于最新证据提供了一系列的循证指导，包括起始治疗的血压水平、药物选择、血压监测目标等</span><span class="s1" style="color: #232323;">8</span><span class="s2" style="color: #232323;">大项推荐。</span></p>, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=274, guiderKeyword=高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=22808, appHits=548, showAppHits=0, pcHits=6769, showPcHits=22238, likes=4, shares=63, comments=25, approvalStatus=1, publishedTime=Mon Aug 30 09:48:22 CST 2021, publishedTimeString=2021-08-26, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=8, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Aug 29 22:42:26 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 20:57:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021年成人高血压药物治疗指南 .pdf)])
2021年成人高血压药物治疗指南 .pdf
下载请点击：
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221107, encodeId=c011122110e33, content=很专业，受教了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLXWO7audMb5MZsYricbQRTPo3hsTFIGloXelHettibdN0BlTg5rVZJtVy7QkaiaoXicAZQNnib4JYKA/132, createdBy=52702374212, createdName=dchsily, createdTime=Fri May 20 09:40:06 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214842, encodeId=38bb12148425d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:27:02 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196447, encodeId=4092119644e78, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=小王大夫123, createdTime=Wed Feb 23 15:44:50 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182712, encodeId=8be31182e12af, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:10:26 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083115, encodeId=f8c11083115ee, content=打卡学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c945447816, createdName=ms6000001392849747, createdTime=Wed Dec 22 16:48:07 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-05-20 dchsily

    很专业，受教了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221107, encodeId=c011122110e33, content=很专业，受教了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLXWO7audMb5MZsYricbQRTPo3hsTFIGloXelHettibdN0BlTg5rVZJtVy7QkaiaoXicAZQNnib4JYKA/132, createdBy=52702374212, createdName=dchsily, createdTime=Fri May 20 09:40:06 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214842, encodeId=38bb12148425d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:27:02 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196447, encodeId=4092119644e78, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=小王大夫123, createdTime=Wed Feb 23 15:44:50 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182712, encodeId=8be31182e12af, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:10:26 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083115, encodeId=f8c11083115ee, content=打卡学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c945447816, createdName=ms6000001392849747, createdTime=Wed Dec 22 16:48:07 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1221107, encodeId=c011122110e33, content=很专业，受教了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLXWO7audMb5MZsYricbQRTPo3hsTFIGloXelHettibdN0BlTg5rVZJtVy7QkaiaoXicAZQNnib4JYKA/132, createdBy=52702374212, createdName=dchsily, createdTime=Fri May 20 09:40:06 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214842, encodeId=38bb12148425d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:27:02 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196447, encodeId=4092119644e78, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=小王大夫123, createdTime=Wed Feb 23 15:44:50 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182712, encodeId=8be31182e12af, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:10:26 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083115, encodeId=f8c11083115ee, content=打卡学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c945447816, createdName=ms6000001392849747, createdTime=Wed Dec 22 16:48:07 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-02-23 小王大夫123

    受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1221107, encodeId=c011122110e33, content=很专业，受教了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLXWO7audMb5MZsYricbQRTPo3hsTFIGloXelHettibdN0BlTg5rVZJtVy7QkaiaoXicAZQNnib4JYKA/132, createdBy=52702374212, createdName=dchsily, createdTime=Fri May 20 09:40:06 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214842, encodeId=38bb12148425d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:27:02 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196447, encodeId=4092119644e78, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=小王大夫123, createdTime=Wed Feb 23 15:44:50 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182712, encodeId=8be31182e12af, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:10:26 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083115, encodeId=f8c11083115ee, content=打卡学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c945447816, createdName=ms6000001392849747, createdTime=Wed Dec 22 16:48:07 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-01-10 ms7000000167247375

    学习#学习#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1221107, encodeId=c011122110e33, content=很专业，受教了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJDLXWO7audMb5MZsYricbQRTPo3hsTFIGloXelHettibdN0BlTg5rVZJtVy7QkaiaoXicAZQNnib4JYKA/132, createdBy=52702374212, createdName=dchsily, createdTime=Fri May 20 09:40:06 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214842, encodeId=38bb12148425d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:27:02 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196447, encodeId=4092119644e78, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=小王大夫123, createdTime=Wed Feb 23 15:44:50 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182712, encodeId=8be31182e12af, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:10:26 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083115, encodeId=f8c11083115ee, content=打卡学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c945447816, createdName=ms6000001392849747, createdTime=Wed Dec 22 16:48:07 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 ms6000001392849747

    打卡学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

成年人精神压力相关高血压诊疗专家共识

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2021-08-10

2021 ESH意见书：高血压和射血分数保留的心力衰竭

欧洲高血压学会(ESH,European Society of Hypertension) · 2021-05-30

2021 AHA科学声明：体育锻炼作为高血压或胆固醇升高一线治疗的重要组成

美国心脏协会(AHA,American Heart Association) · 2021-06-02

2021 昆士兰临床指南：高血压和妊娠

昆士兰卫生组织(QLD,Queensland Health) · 2021-05-01

中国高血压患者心率管理多学科专家共识（2021年版）

暂未更新 · 2021-04-20

中国高龄老年人血压水平适宜范围指南

中华预防医学会(CPMA,Chinese Preventive Medicine Association) · 2021-03-20

拓展阅读

2009ESH 欧洲高血压指南重新评估

欧洲高血压学会(ESH,European Society of Hypertension) · 2009-11-01

2010 台湾高血压管理指南（英文版）

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2010-01-01

2010年中国肺高血压诊治指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

2010高血压患者胆固醇管理临床指导建议

中国心血管相关专家小组（统称） · 2010-02-01

2009年基层版《中国高血压防治指南》

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-02-10

2010 中国急诊高血压管理专家共识

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2010-03-19